Characteristics of patients undergoing medication-assisted -treatment for opioid use disorder and their interest in Tai Chi practice
- PMID: 37644791
- PMCID: PMC10913153
- DOI: 10.5055/jom.2023.0790
Characteristics of patients undergoing medication-assisted -treatment for opioid use disorder and their interest in Tai Chi practice
Abstract
Objectives: (1) To explore the characteristics of patients with opioid use disorder (OUD) maintained on either methadone or buprenorphine and (2) to determine the relative acceptability of integrating Tai Chi (TC) practice into an ongoing medication-assisted treatment for opioid use disorder (MOUD) program.
Design: Survey study.
Setting: The University of Arkansas for Medical Sciences Center for Addiction Services and Treatment Program.
Patients: 97 patients receiving MOUD treatment.
Main outcomes: Drug use history, treatment status, physical limitation, mental health, pain, and whether participants were interested in using TC to improve health outcomes.
Results: At least 30.9 percent of the sample reported moderate or higher level of limitation in performing rigorous physical activities, pain intensity, and pain interference. Between 37.1 and 61.5 percent of the sample reported various psychiatric symptoms. Methadone patients reported higher levels of physical limitations, especially in rigorous activities (p = .012), climbing several flights of stairs (p = .001), and walking more than a mile (p = .011), but similar levels of pain (ps = .664-.689) and psychiatric symptoms (ps = .262-.879) relative to buprenorphine patients. At least 40.2 percent of participants expressed moderate or higher level of interest in TC for improving health outcomes, with methadone patients more interested in participating to ease mental and sleep problems (p = .005) and improve physical fitness (p = .015) compared to buprenorphine patients.
Conclusions: High prevalence of physical limitation, pain, and psychiatric comorbidities were found in OUD patients. Since patients were interested in TC to improve their health outcomes, this low-cost intervention, if proven effective, can be integrated into ongoing MOUD programs to improve health in this population.
Figures
Similar articles
-
Comparison of PACU length of stay and opioid requirements of patients maintained on buprenorphine or methadone for opioid use disorder.J Opioid Manag. 2022 Jan-Feb;18(1):7-15. doi: 10.5055/jom.2022.0689. J Opioid Manag. 2022. PMID: 35238008
-
Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.Hosp Pract (1995). 2022 Oct;50(4):251-258. doi: 10.1080/21548331.2022.2102776. Epub 2022 Jul 22. Hosp Pract (1995). 2022. PMID: 35837678 Review.
-
Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs.Subst Abuse Treat Prev Policy. 2023 May 22;18(1):30. doi: 10.1186/s13011-023-00538-x. Subst Abuse Treat Prev Policy. 2023. PMID: 37217975 Free PMC article.
-
Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder.J Clin Psychol. 2023 Dec;79(12):2869-2883. doi: 10.1002/jclp.23582. Epub 2023 Aug 16. J Clin Psychol. 2023. PMID: 37584532
-
Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.Med Clin North Am. 2020 Jul;104(4):695-708. doi: 10.1016/j.mcna.2020.03.003. Epub 2020 May 12. Med Clin North Am. 2020. PMID: 32505261 Review.
References
-
- Substance Abuse Center for Behavioral Health Statistics and Quality. Results from the 2020 National Survey on Drug Use and Health: detailed tables. Substance Abuse Center for Behavioral Health Statistics and Quality. June 3, 2022. Accessed June 3, 2022. https://nida.nih.gov/download/21349/medications-to-treat-opioid-use-diso...
-
- Council of Economic Advisers, The Underestimated Cost of the Opioid Crisis, E.O.o.t.P.o.t.U. States, Editor. 2017, Executive Office of the President of the United States: Washington, DC.
-
- Hedegaard H, Miniño AM, Warner M. Drug Overdose Deaths in the United States, 1999–2017. NCHS Data Brief. 2018;(329):1–8. - PubMed
-
- Saxon AJ, McCance-Katz EF. Some Additional Considerations Regarding the American Society of Addiction Medicine National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. J Addict Med. May–Jun 2016;10(3):140–2. doi:10.1097/ADM.0000000000000219 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical